Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Murakami, K."'
Publikováno v:
In International Journal of Immunopharmacology 1988 10 Supplement 1:5-5
Autor:
Kuriyama K; Japan Development, Global Vaccine Business Unit, Takeda Pharmaceutical Company Ltd, Osaka, Japan. Electronic address: kenji.kuriyama@takeda.com., Murakami K; Medical Franchise Vaccine, Japan Medical Office, Takeda Pharmaceutical Company Ltd, Tokyo, Japan. Electronic address: kyoko.murakami@takeda.com., Sugiura K; Statistical and Quantitative Sciences, Data Sciences Institute, Takeda Pharmaceutical Company Ltd, Osaka, Japan. Electronic address: kenkichi.sugiura@takeda.com., Sakui S; Statistical and Quantitative Sciences, Data Sciences Institute, Takeda Pharmaceutical Company Ltd, Osaka, Japan. Electronic address: sho.sakui@takeda.com., Schuring RP; Clinical Development, Global Vaccine Business Unit, Takeda Pharmaceuticals International AG, Zurich, Switzerland. Electronic address: ron.schuring@takeda.com., Masuda T; Japan Development, Global Vaccine Business Unit, Takeda Pharmaceutical Company Ltd, Osaka, Japan. Electronic address: taisei.masuda@takeda.com., Mori M; Japan Development, Global Vaccine Business Unit, Takeda Pharmaceutical Company Ltd, Osaka, Japan. Electronic address: mitsuhiro.mori@takeda.com.
Publikováno v:
Vaccine [Vaccine] 2024 Feb 27; Vol. 42 (6), pp. 1319-1325. Date of Electronic Publication: 2024 Feb 02.
Autor:
Palao L 3rd; Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, PA, USA; Biochemistry and Molecular Biophysics Graduate Group, Perelman School of Medicine, University of Pennsylvania, PA, USA., Murakami K; Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, PA, USA; Biochemistry and Molecular Biophysics Graduate Group, Perelman School of Medicine, University of Pennsylvania, PA, USA; Institute of Structural Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: kenjim@pennmedicine.upenn.edu., Chang YW; Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, PA, USA; Biochemistry and Molecular Biophysics Graduate Group, Perelman School of Medicine, University of Pennsylvania, PA, USA; Institute of Structural Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: ywc@pennmedicine.upenn.edu.
Publikováno v:
Current opinion in structural biology [Curr Opin Struct Biol] 2024 Feb; Vol. 84, pp. 102765. Date of Electronic Publication: 2024 Jan 04.
Autor:
Kuriyama K; Japan Development, Global Vaccine Business Unit, Takeda Pharmaceutical Company Ltd, Japan Takeda Pharmaceuticals, Osaka, Japan. Electronic address: kenji.kuriyama@takeda.com., Murakami K; Medical Franchise Vaccine, Japan Medical Office, Takeda Pharmaceutical Company Ltd, Tokyo, Japan. Electronic address: kyoko.murakami@takeda.com., Sugiura K; Statistical and Quantitative Sciences, Data Sciences Institute, Takeda Pharmaceutical Company Ltd, Osaka, Japan. Electronic address: kenkichi.sugiura@takeda.com., Sakui S; Statistical and Quantitative Sciences, Data Sciences Institute, Takeda Pharmaceutical Company Ltd, Osaka, Japan. Electronic address: sho.sakui@takeda.com., Schuring RP; Clinical Development, Global Vaccine Business Unit, Takeda Pharmaceuticals International AG, Zurich, Switzerland. Electronic address: ron.schuring@takeda.com., Mori M; Japan Development, Global Vaccine Business Unit, Takeda Pharmaceutical Company Ltd, Japan Takeda Pharmaceuticals, Osaka, Japan. Electronic address: mitsuhiro.mori@takeda.com.
Publikováno v:
Vaccine [Vaccine] 2024 Jan 25; Vol. 42 (3), pp. 662-670. Date of Electronic Publication: 2023 Dec 21.
Autor:
Kuriyama K; Japan Development, Global Vaccine Business Unit, Takeda Pharmaceutical Company Ltd, Osaka, Japan. Electronic address: kenji.kuriyama@takeda.com., Murakami K; Medical Franchise Vaccine, Japan Medical Office, Takeda Pharmaceutical Company Ltd, Tokyo, Japan. Electronic address: kyoko.murakami@takeda.com., Masuda T; Japan Development, Global Vaccine Business Unit, Takeda Pharmaceutical Company Ltd, Osaka, Japan. Electronic address: taisei.masua@takeda.com., Sugiura K; Statistical and Quantitative Sciences, Data Sciences Institute, Takeda Pharmaceutical Company Ltd, Osaka, Japan. Electronic address: kenkichi.sugiura@takeda.com., Sakui S; Statistical and Quantitative Sciences, Data Sciences Institute, Takeda Pharmaceutical Company Ltd, Osaka, Japan. Electronic address: sho.sakui@takeda.com., Schuring RP; Clinical Development, Global Vaccine Business Unit, Takeda Pharmaceuticals International AG, Zurich, Switzerland. Electronic address: ron.schuring@takeda.com., Mori M; Japan Development, Global Vaccine Business Unit, Takeda Pharmaceutical Company Ltd, Osaka, Japan. Electronic address: mitsuhiro.mori@takeda.com.
Publikováno v:
Vaccine [Vaccine] 2023 Jun 07; Vol. 41 (25), pp. 3763-3771. Date of Electronic Publication: 2023 May 08.
Autor:
Ohta N; Division of Otolaryngology, Tohoku Medical and Pharmaceutical University Hospital, 1-12-1, Fukumuro, Miyaginoku, Sendai 983-8512, Japan; Department of Otolaryngology, Yamagata City Hospital Saiseikan, Yamagata, Japan. Electronic address: noohta@hosp.tohoku-mpu.ac.jp., Suzuki T; Division of Otolaryngology, Tohoku Medical and Pharmaceutical University Hospital, 1-12-1, Fukumuro, Miyaginoku, Sendai 983-8512, Japan., Noguchi N; Division of Otolaryngology, Tohoku Medical and Pharmaceutical University Hospital, 1-12-1, Fukumuro, Miyaginoku, Sendai 983-8512, Japan., Shirane S; Division of Otolaryngology, Tohoku Medical and Pharmaceutical University Hospital, 1-12-1, Fukumuro, Miyaginoku, Sendai 983-8512, Japan., Ansai N; Division of Otolaryngology, Tohoku Medical and Pharmaceutical University Hospital, 1-12-1, Fukumuro, Miyaginoku, Sendai 983-8512, Japan., Sato T; Division of Otolaryngology, Tohoku Medical and Pharmaceutical University Hospital, 1-12-1, Fukumuro, Miyaginoku, Sendai 983-8512, Japan., Ishida Y; Division of Anatomy and Cell Biology, Tohoku Medical and Pharmaceutical University, 1-12-1, Fukumuro, Miyaginoku, Sendai 983-8512, Japan., Murakami K; Division of Pathology, Tohoku Medical and Pharmaceutical University, 1-12-1, Fukumuro, Miyaginoku, Sendai 983-8512, Japan., Murakami K; Division of Pathology, Tohoku Medical and Pharmaceutical University, 1-12-1, Fukumuro, Miyaginoku, Sendai 983-8512, Japan., Nakamura Y; Division of Pathology, Tohoku Medical and Pharmaceutical University, 1-12-1, Fukumuro, Miyaginoku, Sendai 983-8512, Japan.
Publikováno v:
Auris, nasus, larynx [Auris Nasus Larynx] 2023 Apr; Vol. 50 (2), pp. 272-275. Date of Electronic Publication: 2022 Jul 14.
Autor:
Kawamura H; Division of Infectious Diseases and Immunology, Department of Microbiology, School of Medicine, Iwate Medical University, 1-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate 028-3694, Japan; Department of Obstetrics and Gynecology, School of Medicine, Iwate Medical University, 2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate 028-3694, Japan., Yoshino N; Division of Infectious Diseases and Immunology, Department of Microbiology, School of Medicine, Iwate Medical University, 1-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate 028-3694, Japan. Electronic address: nyoshino@iwate-med.ac.jp., Murakami K; Division of Infectious Diseases and Immunology, Department of Microbiology, School of Medicine, Iwate Medical University, 1-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate 028-3694, Japan; Department of Obstetrics and Gynecology, School of Medicine, Iwate Medical University, 2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate 028-3694, Japan., Kawamura H; Division of Infectious Diseases and Immunology, Department of Microbiology, School of Medicine, Iwate Medical University, 1-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate 028-3694, Japan; Department of Obstetrics and Gynecology, School of Medicine, Iwate Medical University, 2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate 028-3694, Japan., Sugiyama I; Division of Advanced Pharmaceutics, Department of Clinical Pharmaceutical Sciences, School of Pharmacy, Iwate Medical University, 1-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate 028-3694, Japan., Sasaki Y; Division of Infectious Diseases and Immunology, Department of Microbiology, School of Medicine, Iwate Medical University, 1-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate 028-3694, Japan., Odagiri T; Division of Infectious Diseases and Immunology, Department of Microbiology, School of Medicine, Iwate Medical University, 1-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate 028-3694, Japan., Sadzuka Y; Division of Advanced Pharmaceutics, Department of Clinical Pharmaceutical Sciences, School of Pharmacy, Iwate Medical University, 1-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate 028-3694, Japan., Muraki Y; Division of Infectious Diseases and Immunology, Department of Microbiology, School of Medicine, Iwate Medical University, 1-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate 028-3694, Japan.
Publikováno v:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2023 Jan; Vol. 182, pp. 1-11. Date of Electronic Publication: 2022 Nov 28.
Autor:
Masuda T; Japan Development, Global Vaccine Business Unit, Takeda Pharmaceutical Company Ltd, Japan. Electronic address: taisei.masuda@takeda.com., Murakami K; Japan Medical and Policy Affairs, Medical Affairs Office, Global Vaccine Business Unit, Takeda Pharmaceutical Company Ltd, Japan. Electronic address: kyoko.murakami@takeda.com., Sugiura K; Statistical and Quantitative Sciences, Data Sciences Institute, Takeda Pharmaceutical Company Ltd, Japan. Electronic address: kenkichi.sugiura@takeda.com., Sakui S; Statistical and Quantitative Sciences, Data Sciences Institute, Takeda Pharmaceutical Company Ltd, Japan. Electronic address: sho.sakui@takeda.com., Schuring RP; Clinical Development, Global Vaccine Business Unit, Takeda Pharmaceuticals International AG, Switzerland. Electronic address: ron.schuring@takeda.com., Mori M; Japan Development, Global Vaccine Business Unit, Takeda Pharmaceutical Company Ltd, Japan. Electronic address: mitsuhiro.mori@takeda.com.
Publikováno v:
Vaccine [Vaccine] 2022 May 26; Vol. 40 (24), pp. 3380-3388. Date of Electronic Publication: 2022 Apr 29.
Autor:
Masuda T; Japan Development, Global Vaccine Business Unit, Takeda Pharmaceutical Company Ltd, Japan. Electronic address: taisei.masuda@takeda.com., Murakami K; Japan Medical and Policy Affairs, Medical Affairs Office, Global Vaccine Business Unit, Takeda Pharmaceutical Company Ltd, Japan. Electronic address: kyoko.murakami@takeda.com., Sugiura K; Statistical and Quantitative Sciences, Data Sciences Institute, Takeda Pharmaceutical Company Ltd, Japan. Electronic address: kenkichi.sugiura@takeda.com., Sakui S; Statistical and Quantitative Sciences, Data Sciences Institute, Takeda Pharmaceutical Company Ltd, Japan. Electronic address: sho.sakui@takeda.com., Philip Schuring R; Clinical Development, Global Vaccine Business Unit, Takeda Pharmaceutical International Ag, Switzerland. Electronic address: ron.schuring@takeda.com., Mori M; Japan Development, Global Vaccine Business Unit, Takeda Pharmaceutical Company Ltd, Japan. Electronic address: mitsuhiro.mori@takeda.com.
Publikováno v:
Vaccine [Vaccine] 2022 Mar 18; Vol. 40 (13), pp. 2044-2052. Date of Electronic Publication: 2022 Feb 08.
Autor:
Keawmanee N; The United Graduate School of Agricultural Science, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu, 501-1193, Japan; Department of Bioresource Sciences, Faculty of Agriculture, Shizuoka University, 836 Ohya, Suruga, Shizuoka, 422-8529, Japan., Ma G; Department of Bioresource Sciences, Faculty of Agriculture, Shizuoka University, 836 Ohya, Suruga, Shizuoka, 422-8529, Japan; Graduate School of Integrated Science and Technology, Shizuoka University, 836 Ohya, Suruga, Shizuoka, 422-8529, Japan., Zhang L; Department of Bioresource Sciences, Faculty of Agriculture, Shizuoka University, 836 Ohya, Suruga, Shizuoka, 422-8529, Japan., Yahata M; Department of Bioresource Sciences, Faculty of Agriculture, Shizuoka University, 836 Ohya, Suruga, Shizuoka, 422-8529, Japan; Graduate School of Integrated Science and Technology, Shizuoka University, 836 Ohya, Suruga, Shizuoka, 422-8529, Japan., Murakami K; Graduate School of Integrated Science and Technology, Shizuoka University, 836 Ohya, Suruga, Shizuoka, 422-8529, Japan., Yamamoto M; Graduate School of Integrated Science and Technology, Shizuoka University, 836 Ohya, Suruga, Shizuoka, 422-8529, Japan., Kojima N; Graduate School of Integrated Science and Technology, Shizuoka University, 836 Ohya, Suruga, Shizuoka, 422-8529, Japan., Kato M; Department of Bioresource Sciences, Faculty of Agriculture, Shizuoka University, 836 Ohya, Suruga, Shizuoka, 422-8529, Japan; Graduate School of Integrated Science and Technology, Shizuoka University, 836 Ohya, Suruga, Shizuoka, 422-8529, Japan. Electronic address: kato.masaya@shizuoka.ac.jp.
Publikováno v:
Plant physiology and biochemistry : PPB [Plant Physiol Biochem] 2022 Jan 15; Vol. 173, pp. 14-24. Date of Electronic Publication: 2022 Jan 22.